Phil Rivers Technology
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $59M
Investors
- 8
About Phil Rivers Technology
, trading as Phil Rivers Technology, is a biotechnology company focusing on AI pharmaceutical R&D. The company's founder, Chunming Zhang is an associate researcher at the Institute of Computing Technology, Chinese Academy of Sciences. The company has built three AI tool platforms including the biomedical knowledge AI platform, virtual clinical trial platform, and AI platform for quantitative assessment of cell function. Its AI platforms can be applied in six scenarios such as new targets, new mechanisms of action, new biomarkers, design clinical trial schemes, predict clinical trial results, and new indications. It is also advancing multiple FIC (First in Class) pipelines including pancreatic cancer, liver cancer, and breast cancer. The company generates revenue from the sales of medicines, service for clinical trial, and clinical treatment. Also, it will continuously improve the basic model matrix, including knowledge models, genome models, signaling pathway models, virtual cell models, and lesion world models, promote the construction of AI intelligent agents and experimental verification systems, and accelerate the industrialization of original targets, innovative drug pipelines, and virtual clinical trials.
Who invested in Phil Rivers Technology
8 investors across 3 rounds
See all investors in Phil Rivers Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phil Rivers Technology
Who invested in Phil Rivers Technology?
Phil Rivers Technology has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phil Rivers Technology raised?
Phil Rivers Technology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Phil Rivers Technology last raise money?
Phil Rivers Technology's most recent round on record is a Series A, in Aug 2026.
What does Phil Rivers Technology do?
, trading as Phil Rivers Technology, is a biotechnology company focusing on AI pharmaceutical R&D.
Where is Phil Rivers Technology headquartered?
Phil Rivers Technology is headquartered in Beijing, China.
Which VCs invest in companies like Phil Rivers Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Phil Rivers Technology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Phil Rivers Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.